Literature DB >> 6109024

Urinary metabolites of timolol from humans and laboratory animals. Syntheses and beta-adrenergic blocking activities.

B K Wasson, J Scheigetz, C S Rooney, R A Hall, N N Share, W J VandenHeuvel, B H Arison, O D Hensens, R L Ellsworth, D J Tocco.   

Abstract

Syntheses are reported for three metabolites (2-4) of timolol (1) formed by oxidative metabolism of the morpholine ring. GLC-MS comparisons are presented which establish that the two metabolites whose structures were previously in question are identical with their synthetic counterparts 2 and 3. In 2, metabolic oxidation of the 4-morpholinyl group of 1 had occurred at the carbon next to oxygen to give the 2-hydroxy-4-morpholinyl moiety, whereas in 3, the morpholine of 1 has been oxidized one step further and then ring opened to produce the N-(2-hydroxyethyl)glycine substituent. Biological testing of synthetic samples of the three major metabolites from human urine (3, 4, and 6) indicated that only 4, in which the morpholine moiety has been degraded to a 2-hydroxyethylamino group, had significant beta-adrenergic blocking activity (one-seventh that of timolol in anesthetized dogs).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6109024     DOI: 10.1021/jm00185a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Timolol metabolism and debrisoquine oxidation polymorphism: a population study.

Authors:  M S Lennard; R V Lewis; L A Brawn; G T Tucker; L E Ramsay; P R Jackson; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

Review 2.  The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.

Authors:  M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

3.  Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics.

Authors:  R V Lewis; M S Lennard; P R Jackson; G T Tucker; L E Ramsay; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

4.  Reactions of glycidyl derivatives with ambident nucleophiles; part 2: amino acid derivatives.

Authors:  Gerald Dyker; Andreas Thöne; Gerald Henkel
Journal:  Beilstein J Org Chem       Date:  2007-09-27       Impact factor: 2.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.